[go: up one dir, main page]

PE20010382A1 - CRYSTALLINE III FORM OF N- (4- (5-DIMETHYLAMINONAPHTHALEN-1-SULFONYLAMINE) PHENYL) -3-HYDROXY-2,2-DIMETHYLPROPIONAMIDE - Google Patents

CRYSTALLINE III FORM OF N- (4- (5-DIMETHYLAMINONAPHTHALEN-1-SULFONYLAMINE) PHENYL) -3-HYDROXY-2,2-DIMETHYLPROPIONAMIDE

Info

Publication number
PE20010382A1
PE20010382A1 PE2000000729A PE0007292000A PE20010382A1 PE 20010382 A1 PE20010382 A1 PE 20010382A1 PE 2000000729 A PE2000000729 A PE 2000000729A PE 0007292000 A PE0007292000 A PE 0007292000A PE 20010382 A1 PE20010382 A1 PE 20010382A1
Authority
PE
Peru
Prior art keywords
iii
dimethylaminonaphthalen
sulfonylamine
dimethylpropionamide
hydroxy
Prior art date
Application number
PE2000000729A
Other languages
Spanish (es)
Inventor
Alfons Grunenberg
Andreas Lender
Andree Folkerts
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PE20010382A1 publication Critical patent/PE20010382A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A LA FORMA CRISTALINA III DE N-(4-(5-DIMETILAMINONAFTALEN-1-SULFONILAMINO)FENIL)-3-HIDROXI-2,2-DIMETILPROPIONAMIDA (DNSP) DE FORMULA I QUE SE CARACTERIZA POR: i)PUNTO DE FUSION DE 140°C, ii)VALORES DE DIFRACCION DE RAYOS X; iii)ESPECTRO RAMAN. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA OBTENCION DE LA FORMA CRISTALINA III DE DNSP CARACTERIZADO PORQUE SE SUSPENDE LA FORMA CRISTALINA I DE DNSP EN AGUA Y/O DISOLVENTES ORGANICOS INERTES A TEMPERATURAS DE 0°C-60°C HASTA LA TRANSFORMACION CUANTITATIVA A LA FORMA CRISTALINA III. LA FORMA CRISTALINA III DE LA N-(4-(5-DIMETILAMINONAFTALEN-1-SULFONILAMINO)FENIL-3-HIDROXI-2,2-DIMETILPROPIONAMIDA PUEDE SER UTIL PARA EL TRATAMIENTO O PROFILAXIS DE ENFERMEDADES CAUSADAS POR CITOMEGALOVIRUS HUMANO (HCMV) EN PACIENTES CON SIDA, CON TRASPLANTES DE MEDULA Y ORGANOS, EN RECIEN NACIDOS Y NINOS PEQUENOSREFERS TO THE CRYSTALLINE III FORM OF N- (4- (5-DIMETHYLAMINONAPHTHALEN-1-SULFONYLAMINE) PHENYL) -3-HYDROXY-2,2-DIMETHYLPROPIONAMIDE (DNSP) OF FORMULA I WHICH IS CHARACTERIZED BY: i) MELTING POINT OF 140 ° C, ii) X-RAY DIFFRACTION VALUES; iii) SPECTRUM RAMAN. IT ALSO REFERS TO A PROCEDURE FOR OBTAINING THE CRYSTALLINE FORM III OF DNSP CHARACTERIZED BECAUSE THE CRYSTALLINE FORM I OF DNSP IS SUSPENDED IN WATER AND / OR INERT ORGANIC SOLVENTS AT TEMPERATURES OF 0 ° C-60 ° C UNTIL THE QUANTITY TRANSFORMATION CRYSTAL FORM III. THE CRYSTALLINE III FORM OF N- (4- (5-DIMETHYLAMINONAPHTHALEN-1-SULFONYLAMINE) PHENYL-3-HYDROXY-2,2-DIMETHYLPROPIONAMIDE MAY BE USEFUL FOR THE TREATMENT OR PROPHYLAXIS OF DISEASES CAUSED BY CYTOMEGALOVENT IN HUMAN PENALOVENTSCM. WITH AIDS, WITH TRANSPLANTATION OF THE MARROW AND ORGANS, IN NEWBORNS AND YOUNG CHILDREN

PE2000000729A 1999-07-21 2000-07-20 CRYSTALLINE III FORM OF N- (4- (5-DIMETHYLAMINONAPHTHALEN-1-SULFONYLAMINE) PHENYL) -3-HYDROXY-2,2-DIMETHYLPROPIONAMIDE PE20010382A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19934295A DE19934295A1 (en) 1999-07-21 1999-07-21 New thermodynamically stable crystal modification III of N-phenyl-naphthalene-sulfonamide derivative, is an antiviral agent especially useful for treating cytomegalovirus infections

Publications (1)

Publication Number Publication Date
PE20010382A1 true PE20010382A1 (en) 2001-06-11

Family

ID=7915608

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000729A PE20010382A1 (en) 1999-07-21 2000-07-20 CRYSTALLINE III FORM OF N- (4- (5-DIMETHYLAMINONAPHTHALEN-1-SULFONYLAMINE) PHENYL) -3-HYDROXY-2,2-DIMETHYLPROPIONAMIDE

Country Status (8)

Country Link
AR (1) AR024797A1 (en)
AU (1) AU6562600A (en)
CO (1) CO5180571A1 (en)
DE (1) DE19934295A1 (en)
GT (1) GT200000114A (en)
PE (1) PE20010382A1 (en)
UY (1) UY26251A1 (en)
WO (1) WO2001007404A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780794B2 (en) 2000-01-20 2004-08-24 Honeywell International Inc. Methods of bonding physical vapor deposition target materials to backing plate materials
US6698647B1 (en) 2000-03-10 2004-03-02 Honeywell International Inc. Aluminum-comprising target/backing plate structures
US7371906B2 (en) * 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
EP2481540B1 (en) 2011-01-28 2017-11-01 Schelling Anlagenbau GmbH Device for sawing at least two plate or plate stack shaped workpieces

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20000532A2 (en) * 1998-01-23 2001-02-28 Bayer Ag Novel naphthyl-substituted and anilide-substituted sulfonamides

Also Published As

Publication number Publication date
WO2001007404A1 (en) 2001-02-01
CO5180571A1 (en) 2002-07-30
DE19934295A1 (en) 2001-01-25
AR024797A1 (en) 2002-10-23
GT200000114A (en) 2002-01-01
UY26251A1 (en) 2001-01-31
AU6562600A (en) 2001-02-13

Similar Documents

Publication Publication Date Title
DK0944617T3 (en) Crystals of benzimidazole derivatives and their preparation
DE60236600D1 (en) SUBSTITUTED 1H-DIHYDROPYRAZOLE, THEIR PREPARATION AND USE
AR044743A1 (en) HERBICIDE, METHOD OF USE, DERIVED FROM REPLACED TIENOPIRIMIDINE, INTERMEDIATE COMPOUNDS, AND PROCEDURES USED TO PRODUCE THEM,
TR200000595T2 (en) 2,3-Diaryl-pyrazolo [1,5-B] pyridazines derivatives, their preparation and their use as inhibitors of cyclooxygenase 2 (COX-2).
PE20030735A1 (en) BENZOTHIAZOLE DERIVATIVES
NO20050418L (en) Condensed pyridines and pyrimidines with TIE2 (TEK) activity
NO166129C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAHYDRO-9H-PYRIDO (3,4-B) INDOLES.
ATE87308T1 (en) 3-ARYLURACILE FOR WEED CONTROL.
CO5670350A2 (en) PROCESS TO PREPARE ACID DERIVATIVES 5- (1,3-OXAZOL-2-IL) BENZOIC
GR79414B (en)
SE9701304D0 (en) Compounds
ES2150808T3 (en) CRYSTALLINE FORM OF (4-TRIFLUOROMETIL) -ANILIDA ACID 5-METHYLISOXAZOLE-4-CARBOXILICO.
DE60311869D1 (en) CRYSTALLINE CEFDINE SALT
PE20010382A1 (en) CRYSTALLINE III FORM OF N- (4- (5-DIMETHYLAMINONAPHTHALEN-1-SULFONYLAMINE) PHENYL) -3-HYDROXY-2,2-DIMETHYLPROPIONAMIDE
DE3072187D1 (en) AGENTS FOR REGULATING PLANT GROWTH, THEIR PRODUCTION AND THEIR USE.
NO20074622L (en) Metabolites for NK-1 antagonists for vomiting
IL166359A0 (en) 3-heterocyclyl substituted benzoic acid derivatives
ID26210A (en) SEFALOSPORIN PURIFICATION PROCESS PURIFICATION
ES462092A1 (en) N-aryl-N'-(cyclo)-alkyl-thioureas and their use as agents for combating animal pests and plant pests
ATE147380T1 (en) HERBICIDAL SULFONYL UREAS, METHOD FOR PRODUCTION AND USE THEREOF
ES555820A0 (en) PROCEDURE FOR THE OBTAINING OF 1-ARIL-5-ALCOXIIMINOALQUILAMINO-PIRAZOLES
GR3001708T3 (en) 1-phenylimidazole-carbon acid amides, process for their preparation and their use as growth regulators
AR055583A1 (en) USE OF PHENYL SEMI CARBONS FOR SEED TREATMENT
ES2128572T3 (en) USE OF CEFEM DERIVATIVES AS ANTIMETASTATIC AGENTS.
DE3677857D1 (en) 2,5-DIMETHYLPYRROL DERIVATIVE, THEIR PRODUCTION AND THEIR USE.

Legal Events

Date Code Title Description
FC Refusal